Drug Substance Integrated Offering
Hovione’s industry-leading particle science and tableting capabilities accelerate your path to commercialization by seamlessly bridging Drug Substance to Drug Product at a single site through a single interface-one project, one team approach.
One-Site-Stop®
The fully integrated One-Site-Stop® approach brings Drug Substance, Particle Engineering, Drug Product, and Device together at a single location – eliminating the need for product transfers between sites or vendors, reducing risk and complexity, and helping you accelerate delivery with greater control and efficiency.
Drug Substance: Complex reaction capabilities
Hovione anticipates and masters complexity, integrating R&D with Operations to effectively navigate new chemical challenges. Our approach ensures seamless scale-up, robust technology transfer, and consistent global compliance. In addition to our custom development and manufacturing capabilities, we offer a portfolio of off-patent APIs, delivering proven solutions with reliable quality and supply.
Particle Engineering: Amorphous Solid Dispersions via Spray Drying platform
As global leader in Amorphous Solid Dispersions via Spray Drying, Hovione addresses critical industry challenges like bioavailability, solubility, and stability. By leveraging proprietary technologies, engineering, and unmatched expertise, we provide scalable solutions to help even the most complex molecules achieve commercial success.
Drug Product: Formulation design
Our commitment to oral Drug Product development is rooted in science-driven processes designed to accelerate development timelines. Hovione leads the industry in Continuous Tableting, combining real-time controls, accelerated scale-up, and purpose-built facilities to set the standard for rapid and reliable delivery of oral solid dosage forms to market. Alongside this advanced platform, our batch tableting capabilities provide the agility and speed required to efficiently develop and launch new oral therapies.
Respiratory journey
Hovione is the only company offering the pharmaceutical industry a fully integrated One-Site-Stop® platform for inhalation and nasal therapies. This integration streamlines the development journey, significantly reducing risk, accelerating market entry, and ensuring sustained therapeutic efficacy.
Why partner with Hovione?
|
Lead with science65+ years of scientific expertise and a global asset footprint power our technology leadership |
|
Stay compliant, without compromiseOur proven regulatory record means you’re in safe hands |
|
Master tough challengesWhen molecules are complex and timelines are tight, we deliver solutions |
|
Scale seamlesslyEnd-to-end expertise ensures smooth transition from clinical to commercial and Drug Substance to Drug Product |
|
Sustain for the futureInnovation that helps you realize efficiencies and meet your sustainability goals |
|
Move fasterDirect access to decision-makers and flexible solutions keep your projects on track |
Contact us to learn how our Drug Substance to Drug Product integration supports your project.